NCT06554509View on ClinicalTrials.gov

Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

236

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

June 25, 2026

Study Completion Date

August 20, 2026

Conditions

Prurigo Nodularis

Interventions

DRUG

SHR-1819 injection

SHR-1819 injection

DRUG

Placebo

placebo

Trial Locations (1)

100032

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY